The Pharmacological Treatment of Neuropathic Pain in Children


Cite item

Full Text

Abstract

The International Association for the Study of Pain (IASP) defines neuropathic pain as pain caused by a lesion or disease of the somatosensory nervous system. It is characterized as a clinical condition in which diagnostic studies reveal an underlying cause of an abnormality in the peripheral or central nervous system. Many common causes of neuropathic pain in adults are rare in children. The purpose of this focused narrative review is, to 1) provide an overview of neuropathic pain in children, 2) highlight unique considerations related to the diagnosis and mechanisms of neuropathic pain in children, and 3) perform a comprehensive analysis of the pharmacological treatments available. We emphasize that data for routine use of pharmacological agents in children with neuropathic pain are largely inferred from adult literature with little research performed on pediatric populations, yet have clear evidence of harms to pediatric patients. Based on these findings, we propose risk mitigation strategies such as utilizing topical treatments whenever possible, assessing pain phenotyping to guide drug class choice, and considering pharmaceuticals in the broader context of the multidisciplinary treatment of pediatric pain. Furthermore, we highlight important directions for future research on pediatric neuropathic pain treatment.

About the authors

Lisa Einhorn

Department of Anesthesiology, Pediatric Division, Duke University School of Medicine

Email: info@benthamscience.net

Jonathan Hudon

Division of Secondary Care, Department of Family Medicine, McGill University Health Centre

Email: info@benthamscience.net

Pablo Ingelmo

Alan Edwards Centre for Pain Research, McGill University

Author for correspondence.
Email: info@benthamscience.net

References

  1. Pain, N. International Association for the Study of Pain., Available from: https://www.iasp-pain.org/resources/terminology/#Neuro-pathicpain
  2. Jensen, T.S.; Baron, R.; Haanpää, M.; Kalso, E.; Loeser, J.D.; Rice, A.S.C.; Treede, R.D. A new definition of neuropathic pain. Pain, 2011, 152(10), 2204-2205. doi: 10.1016/j.pain.2011.06.017 PMID: 21764514
  3. Loeser, J.D. A new way of thinking about pains. Pain, 2022, 163(9), 1670-1674. doi: 10.1097/j.pain.0000000000002583 PMID: 35984381
  4. Shraim, M.A.; Massé-Alarie, H.; Hodges, P.W. Methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: A systematic review. Pain, 2021, 162(4), 1007-1037. doi: 10.1097/j.pain.0000000000002113 PMID: 33136983
  5. Howard, R.F.; Wiener, S.; Walker, S.M. Neuropathic pain in children. Arch. Dis. Child., 2014, 99(1), 84-89. doi: 10.1136/archdischild-2013-304208 PMID: 24114955
  6. Ingelmo, P.M.; Fumagalli, R. Neuropathic pain in children. Minerva Anestesiol., 2004, 70(5), 393-398. PMID: 15181421
  7. Walker, S.M. Neuropathic pain in children: Steps towards improved recognition and management. EBioMedicine, 2020, 62, 103124. doi: 10.1016/j.ebiom.2020.103124 PMID: 33248373
  8. Walco, G.A.; Dworkin, R.H.; Krane, E.J.; LeBel, A.A.; Treede, R.D. Neuropathic pain in children: Special considerations. Mayo Clin. Proc., 2010, 85(3), S33-S41. doi: 10.4065/mcp.2009.0647 PMID: 20194147
  9. Konijnenberg, A.Y.; Uiterwaal, C.S.; Kimpen, J.L.; van der Hoeven, J.; Buitelaar, J.K.; de Graeff-Meeder, E.R. Children with unexplained chronic pain: Substantial impairment in everyday life. Arch. Dis. Child., 2005, 90(7), 680-686. doi: 10.1136/adc.2004.056820 PMID: 15899922
  10. Friedrichsdorf, S.; Giordano, J.; Desai Dakoji, K.; Warmuth, A.; Daughtry, C.; Schulz, C. Chronic pain in children and adolescents: Diagnosis and treatment of primary pain disorders in head, abdomen, muscles and joints. Children (Basel), 2016, 3(4), 42. doi: 10.3390/children3040042 PMID: 27973405
  11. Baron, R.; Tölle, T.R.; Gockel, U.; Brosz, M.; Freynhagen, R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain, 2009, 146(1), 34-40. doi: 10.1016/j.pain.2009.06.001 PMID: 19592166
  12. Gottrup, H.; Kristensen, A.D.; Bach, F.W.; Jensen, T.S. Aftersensations in experimental and clinical hypersensitivity. Pain, 2003, 103(1), 57-64. doi: 10.1016/S0304-3959(02)00415-3 PMID: 12749959
  13. Katz, J.; Melzack, R. Referred sensations in chronic pain patients. Pain, 1987, 28(1), 51-59. doi: 10.1016/0304-3959(87)91059-1 PMID: 3822494
  14. Anghelescu, D.L.; Steen, B.D.; Wu, H.; Wu, J.; Daw, N.C.; Rao, B.N.; Neel, M.D.; Navid, F. Prospective study of neuropathic pain after definitive surgery for extremity osteosarcoma in a pediatric population. Pediatr. Blood Cancer, 2017, 64(3), e26162. doi: 10.1002/pbc.26162 PMID: 27573717
  15. Yeung, K.K.; Engle, L.; Rabel, A.; Adamson, K.; Schwellnus, H.; Evans, C. It just feels weird!: A qualitative study of how children aged 10-18 years describe neuropathic pain. Disabil. Rehabil., 2017, 39(17), 1695-1702. doi: 10.1080/09638288.2016.1207107 PMID: 27684213
  16. Voepel-Lewis, T.; Merkel, S.; Tait, A.R.; Trzcinka, A.; Malviya, S. The reliability and validity of the Face, Legs, Activity, Cry, Consolability observational tool as a measure of pain in children with cognitive impairment. Anesth. Analg., 2002, 95(5), 1224-1229. doi: 10.1097/00000539-200211000-00020 PMID: 12401598
  17. McGrath, P.J.; Walco, G.A.; Turk, D.C.; Dworkin, R.H.; Brown, M.T.; Davidson, K.; Eccleston, C.; Finley, G.A.; Goldschneider, K.; Haverkos, L.; Hertz, S.H.; Ljungman, G.; Palermo, T.; Rappaport, B.A.; Rhodes, T.; Schechter, N.; Scott, J.; Sethna, N.; Svensson, O.K.; Stinson, J.; von Baeyer, C.L.; Walker, L.; Weisman, S.; White, R.E.; Zajicek, A.; Zeltzer, L. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J. Pain, 2008, 9(9), 771-783. doi: 10.1016/j.jpain.2008.04.007 PMID: 18562251
  18. Romanò, C.L.; Romanò, D.; Lacerenza, M. Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: A systematic review. Pain Res. Treat., 2012, 2012, 1-8. doi: 10.1155/2012/154781 PMID: 22619711
  19. Finnerup, N.B.; Kuner, R.; Jensen, T.S. Neuropathic pain: From mechanisms to treatment. Physiol. Rev., 2021, 101(1), 259-301. doi: 10.1152/physrev.00045.2019 PMID: 32584191
  20. Bennett, M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain, 2001, 92(1), 147-157. doi: 10.1016/S0304-3959(00)00482-6 PMID: 11323136
  21. Bouhassira, D.; Attal, N.; Alchaar, H.; Boureau, F.; Brochet, B.; Bruxelle, J.; Cunin, G.; Fermanian, J.; Ginies, P.; Grun-Overdyking, A.; Jafari-Schluep, H.; Lantéri-Minet, M.; Laurent, B.; Mick, G.; Serrie, A.; Valade, D.; Vicaut, E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain, 2005, 114(1), 29-36. doi: 10.1016/j.pain.2004.12.010 PMID: 15733628
  22. Krause, S.J.; Backonja, M.M. Development of a neuropathic pain questionnaire. Clin. J. Pain, 2003, 19(5), 306-314. doi: 10.1097/00002508-200309000-00004 PMID: 12966256
  23. Finnerup, N.B.; Haroutounian, S.; Kamerman, P.; Baron, R.; Bennett, D.L.H.; Bouhassira, D.; Cruccu, G.; Freeman, R.; Hansson, P.; Nurmikko, T.; Raja, S.N.; Rice, A.S.C.; Serra, J.; Smith, B.H.; Treede, R.D.; Jensen, T.S. Neuropathic pain: An updated grading system for research and clinical practice. Pain, 2016, 157(8), 1599-1606. doi: 10.1097/j.pain.0000000000000492 PMID: 27115670
  24. Treede, R.D.; Jensen, T.S.; Campbell, J.N.; Cruccu, G.; Dostrovsky, J.O.; Griffin, J.W.; Hansson, P.; Hughes, R.; Nurmikko, T.; Serra, J. Neuropathic pain: Redefinition and a grading system for clinical and research purposes. Neurology, 2008, 70(18), 1630-1635. doi: 10.1212/01.wnl.0000282763.29778.59 PMID: 18003941
  25. Bouhassira, D.; Attal, N. Diagnosis and assessment of neuropathic pain: The saga of clinical tools. Pain, 2011, 152(3), S74-S83. doi: 10.1016/j.pain.2010.11.027 PMID: 21185120
  26. Rolke, R.; Baron, R.; Maier, C.; Tölle, T.R.; Treede, D.R.; Beyer, A.; Binder, A.; Birbaumer, N.; Birklein, F.; Bötefür, I.C.; Braune, S.; Flor, H.; Huge, V.; Klug, R.; Landwehrmeyer, G.B.; Magerl, W.; Maihöfner, C.; Rolko, C.; Schaub, C.; Scherens, A.; Sprenger, T.; Valet, M.; Wasserka, B. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values. Pain, 2006, 123(3), 231-243. doi: 10.1016/j.pain.2006.01.041 PMID: 16697110
  27. Blankenburg, M.; Boekens, H.; Hechler, T.; Maier, C.; Krumova, E.; Scherens, A.; Magerl, W.; Aksu, F.; Zernikow, B. Reference values for quantitative sensory testing in children and adolescents: Developmental and gender differences of somatosensory perception. Pain, 2010, 149(1), 76-88. doi: 10.1016/j.pain.2010.01.011 PMID: 20138430
  28. Ramaswamy, S.; Wodehouse, T. Conditioned pain modulation-A comprehensive review. Neurophysiol. Clin., 2021, 51(3), 197-208. doi: 10.1016/j.neucli.2020.11.002 PMID: 33334645
  29. Bruneau, A.; Carrié, S.; Moscaritolo, L.; Ingelmo, P. Mechanism-based pharmacological treatment for chronic non-cancer pain in adolescents: Current approaches and future directions. Paediatr. Drugs, 2022, 24(6), 573-583. doi: 10.1007/s40272-022-00534-x PMID: 36053398
  30. Bruneau, A.; Ferland, C.E.; Pérez-Medina-Carballo, R.; Somaini, M.; Mohamed, N.; Curatolo, M.; Ouellet, J.A.; Ingelmo, P. Association between the use of quantitative sensory testing and conditioned pain modulation and the prescription of medication and interventional procedures in children with chronic pain conditions. Children (Basel), 2022, 9(8), 1157. doi: 10.3390/children9081157 PMID: 36010048
  31. Colloca, L.; Ludman, T.; Bouhassira, D.; Baron, R.; Dickenson, A.H.; Yarnitsky, D.; Freeman, R.; Truini, A.; Attal, N.; Finnerup, N.B.; Eccleston, C.; Kalso, E.; Bennett, D.L.; Dworkin, R.H.; Raja, S.N. Neuropathic pain. Nat. Rev. Dis. Primers, 2017, 3(1), 17002. doi: 10.1038/nrdp.2017.2 PMID: 28205574
  32. Kocot-Kępska, M.; Zajączkowska, R.; Mika, J.; Wordliczek, J.; Dobrogowski, J.; Przeklasa-Muszyńska, A. Peripheral mechanisms of neuropathic pain-the role of neuronal and non-neuronal interactions and their implications for topical treatment of neuropathic pain. Pharmaceuticals (Basel), 2021, 14(2), 77. doi: 10.3390/ph14020077 PMID: 33498496
  33. Burma, N.E.; Leduc-Pessah, H.; Fan, C.Y.; Trang, T. Animal models of chronic pain: Advances and challenges for clinical translation. J. Neurosci. Res., 2017, 95(6), 1242-1256. doi: 10.1002/jnr.23768 PMID: 27376591
  34. Jaggi, A.S.; Jain, V.; Singh, N. Animal models of neuropathic pain. Fundam. Clin. Pharmacol., 2011, 25(1), 1-28. doi: 10.1111/j.1472-8206.2009.00801.x PMID: 20030738
  35. Decosterd, I.; Woolf, C.J. Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain, 2000, 87(2), 149-158. doi: 10.1016/S0304-3959(00)00276-1 PMID: 10924808
  36. Bennett, G.J.; Xie, Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 1988, 33(1), 87-107. doi: 10.1016/0304-3959(88)90209-6 PMID: 2837713
  37. Gilron, I.; Baron, R.; Jensen, T. Neuropathic pain: Principles of diagnosis and treatment. Mayo Clin. Proc., 2015, 90(4), 532-545. doi: 10.1016/j.mayocp.2015.01.018 PMID: 25841257
  38. Ririe, D.G.; Eisenach, J.C. Age-dependent responses to nerve injury-induced mechanical allodynia. Anesthesiology, 2006, 104(2), 344-350. doi: 10.1097/00000542-200602000-00021 PMID: 16436855
  39. Lee, D.H.; Chung, J.M. Neuropathic pain in neonatal rats. Neurosci. Lett., 1996, 209(2), 140-142. doi: 10.1016/0304-3940(96)12623-9 PMID: 8762002
  40. Howard, R.F.; Walker, S.M.; Mota, M.P.; Fitzgerald, M. The ontogeny of neuropathic pain: Postnatal onset of mechanical allodynia in rat spared nerve injury (SNI) and chronic constriction injury (CCI) models. Pain, 2005, 115(3), 382-389. doi: 10.1016/j.pain.2005.03.016 PMID: 15911165
  41. Fitzgerald, M.; McKelvey, R. Nerve injury and neuropathic pain-A question of age. Exp. Neurol., 2016, 275(Pt 2), 296-302. doi: 10.1016/j.expneurol.2015.07.013 PMID: 26220898
  42. Anand, P.; Birch, R. Restoration of sensory function and lack of long-term chronic pain syndromes after brachial plexus injury in human neonates. Brain, 2002, 125(1), 113-122. doi: 10.1093/brain/awf017 PMID: 11834597
  43. Atherton, D.D.; Taherzadeh, O.; Elliot, D.; Anand, P. Age-dependent development of chronic neuropathic pain, allodynia and sensory recovery after upper limb nerve injury in children. J. Hand Surg. Eur. Vol., 2008, 33(2), 186-191. doi: 10.1177/1753193408087029 PMID: 18443061
  44. Vega-Avelaira, D.; McKelvey, R.; Hathway, G.; Fitzgerald, M. The emergence of adolescent onset pain hypersensitivity following neonatal nerve injury. Mol. Pain, 2012, 8, 1744-8069-8-30. doi: 10.1186/1744-8069-8-30 PMID: 22531549
  45. McKelvey, R.; Berta, T.; Old, E.; Ji, R.R.; Fitzgerald, M. Neuropathic pain is constitutively suppressed in early life by anti-inflammatory neuroimmune regulation. J. Neurosci., 2015, 35(2), 457-466. doi: 10.1523/JNEUROSCI.2315-14.2015 PMID: 25589741
  46. Hermann, C.; Hohmeister, J.; Demirakça, S.; Zohsel, K.; Flor, H. Long-term alteration of pain sensitivity in school-aged children with early pain experiences. Pain, 2006, 125(3), 278-285. doi: 10.1016/j.pain.2006.08.026 PMID: 17011707
  47. Beggs, S.; Currie, G.; Salter, M.W.; Fitzgerald, M.; Walker, S.M. Priming of adult pain responses by neonatal pain experience: maintenance by central neuroimmune activity. Brain, 2012, 135(2), 404-417. doi: 10.1093/brain/awr288 PMID: 22102650
  48. Ren, K.; Anseloni, V.; Zou, S.P.; Wade, B.E.; Novikova, I.S.; Ennis, M.; Traub, J.R.; Gold, S.M.; Dubner, R.; Lidow, S.M. Characterization of basal and re-inflammation-associated long-term alteration in pain responsivity following short-lasting neonatal local inflamatory insult. Pain, 2004, 110(3), 588-596. doi: 10.1016/j.pain.2004.04.006 PMID: 15288399
  49. Taddio, A.; Goldbach, M.; Ipp, M.; Stevens, B.; Koren, G. Effect of neonatal circumcision on pain responses during vaccination in boys. Lancet, 1995, 345(8945), 291-292. doi: 10.1016/S0140-6736(95)90278-3 PMID: 7837863
  50. Scheffel, J.; Regen, T.; Van Rossum, D.; Seifert, S.; Ribes, S.; Nau, R.; Parsa, R.; Harris, R.A.; Boddeke, H.W.G.M.; Chuang, H.N.; Pukrop, T.; Wessels, J.T.; Jürgens, T.; Merkler, D.; Brück, W.; Schnaars, M.; Simons, M.; Kettenmann, H.; Hanisch, U.K. Toll-like receptor activation reveals developmental reorganization and unmasks responder subsets of microglia. Glia, 2012, 60(12), 1930-1943. doi: 10.1002/glia.22409 PMID: 22911652
  51. Melzack, R.; Israel, R.; Lacroix, R.; Schultz, G. Phantom limbs in people with congenital limb deficiency or amputation in early childhood. Brain, 1997, 120(9), 1603-1620. doi: 10.1093/brain/120.9.1603 PMID: 9313643
  52. Cooper, T.E.; Wiffen, P.J.; Heathcote, L.C.; Clinch, J.; Howard, R.; Krane, E.; Lord, S.M.; Sethna, N.; Schechter, N.; Wood, C. Antiepileptic drugs for chronic non-cancer pain in children and adolescents. Cochrane Libr., 2017, 8(8), CD012536. doi: 10.1002/14651858.CD012536.pub2 PMID: 28779491
  53. Cooper, T.E.; Heathcote, L.C.; Clinch, J.; Gold, J.I.; Howard, R.; Lord, S.M.; Schechter, N.; Wood, C.; Wiffen, P.J. Antidepressants for chronic non-cancer pain in children and adolescents. Cochrane Database Syst. Rev., 2017, 8(8), CD012535. PMID: 28779487
  54. Cooper, T.E.; Fisher, E.; Gray, A.L.; Krane, E.; Sethna, N.; van Tilburg, M.A.; Zernikow, B.; Wiffen, P.J. Opioids for chronic non-cancer pain in children and adolescents. Cochrane Database Syst. Rev., 2017, 7(7), CD012538. PMID: 28745394
  55. Eccleston, C.; Fisher, E.; Cooper, T.E.; Grégoire, M.C.; Heathcote, L.C.; Krane, E.; Lord, S.M.; Sethna, N.F.; Anderson, A.K.; Anderson, B.; Clinch, J.; Gray, A.L.; Gold, J.I.; Howard, R.F.; Ljungman, G.; Moore, R.A.; Schechter, N.; Wiffen, P.J.; Wilkinson, N.M.R.; Williams, D.G.; Wood, C.; van Tilburg, M.A.L.; Zernikow, B. Pharmacological interventions for chronic pain in children: An overview of systematic reviews. Pain, 2019, 160(8), 1698-1707. doi: 10.1097/j.pain.0000000000001609 PMID: 31335640
  56. World Health Organization. Guidelines on the management of chronic pain in children., 2020. Available from: https://www.who.int/publications/i/item/9789240017870
  57. Taylor, C.P. Mechanisms of action of gabapentin. Rev. Neurol. (Paris), 1997, 153(Suppl. 1), S39-S45. PMID: 9686247
  58. Abdi, S.; Lee, D.H.; Chung, J.M. The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth. Analg., 1998, 87(6), 1360-1366. doi: 10.1213/00000539-199812000-00027 PMID: 9842827
  59. Donado, C.; Nedeljkovic, K.; Wangnamthip, S.; Solodiuk, J.C.; Bourgeois, F.T.; Berde, C.B. Trends in gabapentin and pregabalin prescribing in a tertiary pediatric medical center. Hosp. Pediatr., 2021, 11(8), 909-914. doi: 10.1542/hpeds.2020-003582 PMID: 34257145
  60. Akkurt, H.E. Gümüş H.; Göksu, H.; Odabaşı Ö.F.; Yılmaz, H. Gabapentin treatment for neuropathic pain in a child with sciatic nerve injury. Case Rep. Med., 2015, 2015, 1-3. doi: 10.1155/2015/873157 PMID: 26346828
  61. Saroyan, J.M.; Winfree, C.J.; Schechter, W.S.; Roye, D.; Gold, A.P. Sciatic neuropathy after lower-extremity trauma: successful treatment of an uncommon pain and disability syndrome in an adolescent. Am. J. Phys. Med. Rehabil., 2007, 86(7), 597-600. doi: 10.1097/PHM.0b013e31806dbdd2 PMID: 17581294
  62. Ries, M.; Mengel, E.; Kutschke, G.; Kim, K.S.; Birklein, F.; Krummenauer, F.; Beck, M. Use of gabapentin to reduce chronic neuropathic pain in Fabry disease. J. Inherit. Metab. Dis., 2003, 26(4), 413-414. doi: 10.1023/A:1025127723729 PMID: 12971431
  63. Rusy, L.M.; Troshynski, T.J.; Weisman, S.J. Gabapentin in phantom limb pain management in children and young adults: report of seven cases. J. Pain Symptom Manage., 2001, 21(1), 78-82. doi: 10.1016/S0885-3924(00)00243-8 PMID: 11223317
  64. Kaul, I.; Amin, A.; Rosenberg, M.; Rosenberg, L.; Meyer, W.J., III Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review. Burns, 2018, 44(2), 414-422. doi: 10.1016/j.burns.2017.07.018 PMID: 28822592
  65. Vondracek, P.; Oslejskova, H.; Kepak, T.; Mazanek, P.; Sterba, J.; Rysava, M.; Gal, P. Efficacy of pregabalin in neuropathic pain in paediatric oncological patients. Eur. J. Paediatr. Neurol., 2009, 13(4), 332-336. doi: 10.1016/j.ejpn.2008.06.011 PMID: 18774740
  66. Anghelescu, D.L.; Faughnan, L.G.; Jeha, S.; Relling, M.V.; Hinds, P.S.; Sandlund, J.T.; Cheng, C.; Pei, D.; Hankins, G.; Pauley, J.L.; Pui, C.H. Neuropathic pain during treatment for childhood acute lymphoblastic leukemia. Pediatr. Blood Cancer, 2011, 57(7), 1147-1153. doi: 10.1002/pbc.23039 PMID: 21319291
  67. Anghelescu, D.L.; Tesney, J.M.; Jeha, S.; Wright, B.B.; Trujillo, L.; Sandlund, J.T.; Pauley, J.; Cheng, C.; Pei, D.; Pui, C.H. Prospective randomized trial of interventions for vincristine‐related neuropathic pain. Pediatr. Blood Cancer, 2020, 67(9), e28539. doi: 10.1002/pbc.28539 PMID: 32618122
  68. Anghelescu, D.L.; Tesney, J.M. Neuropathic pain in pediatric oncology: A clinical decision algorithm. Paediatr. Drugs, 2019, 21(2), 59-70. doi: 10.1007/s40272-018-00324-4 PMID: 30761460
  69. Friedrichsdorf, S.J.; Nugent, A.P. Management of neuropathic pain in children with cancer. Curr. Opin. Support. Palliat. Care, 2013, 7(2), 131-138. doi: 10.1097/SPC.0b013e3283615ebe PMID: 23635878
  70. Coluzzi, F.; Rocco, M.; Green Gladden, R.; Persiani, P.; Thur, L.A.; Milano, F. Pain management in childhood leukemia: Diagnosis and available analgesic treatments. Cancers (Basel), 2020, 12(12), 3671. doi: 10.3390/cancers12123671 PMID: 33297484
  71. Brown, S.; Johnston, B.; Amaria, K.; Watkins, J.; Campbell, F.; Pehora, C.; McGrath, P. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children. Scand. J. Pain, 2016, 13(1), 156-163. doi: 10.1016/j.sjpain.2016.05.039 PMID: 28850523
  72. Molero, Y.; Larsson, H.; D’Onofrio, B.M.; Sharp, D.J.; Fazel, S. Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: Population based cohort study in Sweden. BMJ, 2019, 365, l2147. doi: 10.1136/bmj.l2147 PMID: 31189556
  73. M Peckham, A.; Ananickal, M.; Sclar, D. Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance. Risk Manag. Healthc. Policy, 2018, 11, 109-116. doi: 10.2147/RMHP.S168504 PMID: 30154674
  74. Li, D.; Huang, S.; Wang, X.; Yang, L.; Song, T. Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children. Front. Neurol., 2022, 13, 924057. doi: 10.3389/fneur.2022.924057 PMID: 35968281
  75. De Caro, C.; Cristiano, C.; Avagliano, C.; Cuozzo, M.; La Rana, G.; Aviello, G.; De Sarro, G.; Calignano, A.; Russo, E.; Russo, R. Analgesic and anti-inflammatory effects of perampanel in acute and chronic pain models in mice: interaction with the cannabinergic system. Front. Pharmacol., 2021, 11, 620221. doi: 10.3389/fphar.2020.620221 PMID: 33597883
  76. Khangura, R.K.; Bali, A.; Kaur, G.; Singh, N.; Jaggi, A.S. Neuropathic pain attenuating effects of perampanel in an experimental model of chronic constriction injury in rats. Biomed. Pharmacother., 2017, 94, 557-563. doi: 10.1016/j.biopha.2017.07.137 PMID: 28780471
  77. Hara, K.; Haranishi, Y.; Terada, T. Intrathecally administered perampanel alleviates neuropathic and inflammatory pain in rats. Eur. J. Pharmacol., 2020, 872, 172949. doi: 10.1016/j.ejphar.2020.172949 PMID: 31991141
  78. Chang, M.C.; Park, D. Effectiveness of perampanel in managing chronic pain caused by the complex regional pain syndrome. Medicine (Baltimore), 2021, 100(48), e27791. doi: 10.1097/MD.0000000000027791 PMID: 35049177
  79. Finnerup, N.B.; Attal, N.; Haroutounian, S.; McNicol, E.; Baron, R.; Dworkin, R.H.; Gilron, I.; Haanpää, M.; Hansson, P.; Jensen, T.S.; Kamerman, P.R.; Lund, K.; Moore, A.; Raja, S.N.; Rice, A.S.C.; Rowbotham, M.; Sena, E.; Siddall, P.; Smith, B.H.; Wallace, M. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol., 2015, 14(2), 162-173. doi: 10.1016/S1474-4422(14)70251-0 PMID: 25575710
  80. National Institute for Health and Care Excellence. Neuropathic pain in adults: pharacological management in non-specialist settings., Available from: https://www.nice.org.uk/guidance/cg173/chapter/Recommendations
  81. Bates, D.; Schultheis, B.C.; Hanes, M.C.; Jolly, S.M.; Chakravarthy, K.V.; Deer, T.R.; Levy, R.M.; Hunter, C.W. A comprehensive algorithm for management of neuropathic pain. Pain Med., 2019, 20(Suppl. 1), S2-S12. doi: 10.1093/pm/pnz075 PMID: 31152178
  82. Moulin, D.E.; Boulanger, A.; Clark, A.J.; Clarke, H.; Dao, T.; Finley, G.A.; Furlan, A.; Gilron, I.; Gordon, A.; Morley-Forster, P.K.; Sessle, B.J.; Squire, P.; Stinson, J.; Taenzer, P.; Velly, A.; Ware, M.A.; Weinberg, E.L.; Williamson, O.D. Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society. Pain Res. Manag., 2014, 19(6), 328-335. doi: 10.1155/2014/754693 PMID: 25479151
  83. Windsor, R.B.; Sierra, M.; Zappitelli, M.; McDaniel, M. Beyond Amitriptyline: A pediatric and adolescent oriented narrative review of the analgesic properties of psychotropic medications for the treatment of complex pain and headache disorders. Children (Basel), 2020, 7(12), 268. doi: 10.3390/children7120268 PMID: 33276542
  84. Jackson, K.C., II; St Onge, E.L. Antidepressant pharmacotherapy: Considerations for the pain clinician. Pain Pract., 2003, 3(2), 135-143. doi: 10.1046/j.1533-2500.2003.03020.x PMID: 17163912
  85. Saps, M.; Youssef, N.; Miranda, A.; Nurko, S.; Hyman, P.; Cocjin, J.; Di Lorenzo, C. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology, 2009, 137(4), 1261-1269. doi: 10.1053/j.gastro.2009.06.060 PMID: 19596010
  86. de Bruijn, C.M.; Rexwinkel, R.; Gordon, M.; Benninga, M.; Tabbers, M.M. Antidepressants for functional abdominal pain disorders in children and adolescents. Cochrane Database Syst Rev., 2021, 2(2), CD008013.2.
  87. Wilder, R.T.; Berde, C.B.; Wolohan, M.; Vieyra, M.A.; Masek, B.J.; Micheli, L.J. Reflex sympathetic dystrophy in children. Clinical characteristics and follow-up of seventy patients. J. Bone Joint Surg. Am., 1992, 74(6), 910-919. doi: 10.2106/00004623-199274060-00013 PMID: 1634582
  88. Politei, J.M.; Bouhassira, D.; Germain, D.P.; Goizet, C.; Guerrero-Sola, A.; Hilz, M.J.; Hutton, E.J.; Karaa, A.; Liguori, R.; Üçeyler, N.; Zeltzer, L.K.; Burlina, A. Pain in fabry disease: Practical recommendations for diagnosis and treatment. CNS Neurosci. Ther., 2016, 22(7), 568-576. doi: 10.1111/cns.12542 PMID: 27297686
  89. Moore, R.A.; Derry, S.; Aldington, D.; Cole, P.; Wiffen, P.J. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst. Rev., 2015, 2015(7), CD008242. PMID: 26146793
  90. Moore, R.A.; Derry, S.; Aldington, D.; Cole, P.; Wiffen, P.J. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst. Rev., 2012, 12, CD008242. PMID: 23235657
  91. Hearn, L.; Moore, R.A.; Derry, S.; Wiffen, P.J.; Phillips, T. Desipramine for neuropathic pain in adults. Cochrane Database Syst. Rev., 2014, 2014(9), CD011003. PMID: 25246131
  92. Dharmshaktu, P.; Tayal, V.; Kalra, B.S. Efficacy of antidepressants as analgesics: A review. J. Clin. Pharmacol., 2012, 52(1), 6-17. doi: 10.1177/0091270010394852 PMID: 21415285
  93. Max, M.B.; Lynch, S.A.; Muir, J.; Shoaf, S.E.; Smoller, B.; Dubner, R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N. Engl. J. Med., 1992, 326(19), 1250-1256. doi: 10.1056/NEJM199205073261904 PMID: 1560801
  94. Lunn, M.P.; Hughes, R.A.; Wiffen, P.J. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2, 2014, 3(1), CD007115. doi: 10.1002/14651858.CD007115.pub3 PMID: 24385423
  95. Okuma, K.; Shiraishi, K.; Kanai, Y.; Nakagawa, K. Improvement in quality of life by using duloxetine for chemotherapy-induced peripheral neuropathy (CIPN): A case report. Support. Care Cancer, 2016, 24(11), 4483-4485. doi: 10.1007/s00520-016-3349-1 PMID: 27448406
  96. Meng, J.; Zhang, Q.; Yang, C.; Xiao, L.; Xue, Z.; Zhu, J. Duloxetine, a balanced serotonin-norepinephrine reuptake inhibitor, improves painful chemotherapy-induced peripheral neuropathy by inhibiting activation of p38 MAPK and NF-κB. Front. Pharmacol., 2019, 10, 365. doi: 10.3389/fphar.2019.00365 PMID: 31024320
  97. Meighen, K.G. Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder. J. Child Adolesc. Psychopharmacol., 2007, 17(1), 121-127. doi: 10.1089/cap.2006.0042 PMID: 17343560
  98. Desarkar, P.; Das, A.; Sinha, V.K. Duloxetine for childhood depression with pain and dissociative symptoms. Eur. Child Adolesc. Psychiatry, 2006, 15(8), 496-499. doi: 10.1007/s00787-006-0553-4 PMID: 16732464
  99. Kachko, L.; Ben Ami, S.; Liberman, A.; Birk, E.; Kronenberg, S. Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid ‘reactive depression’ in an adolescent. Pain Res. Manag., 2011, 16(6), 457-459. doi: 10.1155/2011/164984 PMID: 22184557
  100. Burghardt, K.J.; Thomas, S.T.; Tutag-Lehr, V. Off-label use of duloxetine for pediatric neuropathic pain. Ment. Health Clin., 2015, 5(6), 277-283. doi: 10.9740/mhc.2015.11.277
  101. Baig, M.U.; Madden, K.; Moody, K. Hyponatremia with antidepressant: A rare side effect from duloxetine in a child with acute leukemia. J. Palliat. Med., 2022, 25(12), 1884-1887. doi: 10.1089/jpm.2021.0526 PMID: 35537479
  102. Semenchuk, M.R.; Davis, B. Efficacy of sustained-release bupropion in neuropathic pain: An open-label study. Clin. J. Pain, 2000, 16(1), 6-11. doi: 10.1097/00002508-200003000-00002 PMID: 10741812
  103. Semenchuk, M.R.; Sherman, S.; Davis, B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology, 2001, 57(9), 1583-1588. doi: 10.1212/WNL.57.9.1583 PMID: 11706096
  104. Valentino, R.J.; Volkow, N.D. Untangling the complexity of opioid receptor function. Neuropsychopharmacology, 2018, 43(13), 2514-2520. doi: 10.1038/s41386-018-0225-3 PMID: 30250308
  105. Windsor, R.B.; Tham, S.W.; Adams, T.L.; Anderson, A. The use of opioids for treatment of pediatric neuropathic pain. Clin. J. Pain, 2019, 35(6), 509-514. doi: 10.1097/AJP.0000000000000712 PMID: 30985402
  106. McNicol, E.D.; Midbari, A.; Eisenberg, E. Opioids for neuropathic pain. Cochrane Database Syst. Rev., 2013, 2013(8), CD006146. PMID: 23986501
  107. Duehmke, R.M.; Derry, S.; Wiffen, P.J.; Bell, R.F.; Aldington, D.; Moore, R.A. Tramadol for neuropathic pain in adults. Cochrane Database Syst. Rev., 2017, 6(6), CD003726. PMID: 28616956
  108. FDA Drug Safety Communication. FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children., Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020281s039lbl.pdf
  109. Finkel, J.C.; Goldberg, J.; Rosenburg, R.; Ariyawansa, J.; Sun, T.; Ochs-Ross, R.; Zannikos, P.; Zhang, L.; Etropolski, M. First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to
  110. Muse, D.; Tarau, E.; Lefeber, C.; Sohns, M.; Brett, M.; Goldberg, J.; Rosenburg, R. Pharmacokinetics, safety, and efficacy of tapentadol oral solution for treating moderate to severe pain in pediatric patients. J. Pain Res., 2019, 12, 1777-1790. doi: 10.2147/JPR.S197039 PMID: 31213888
  111. Johnson, P.N.; Boyles, K.A.; Miller, J.L. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy, 2012, 32(2), 148-157. doi: 10.1002/PHAR.1001 PMID: 22392424
  112. Tobias, J.D. Methadone: Applications in pediatric anesthesiology and critical care medicine. J. Anesth., 2021, 35(1), 130-141. doi: 10.1007/s00540-020-02887-4 PMID: 33432486
  113. Dervan, L.A.; Yaghmai, B.; Watson, R.S.; Wolf, F.M. The use of methadone to facilitate opioid weaning in pediatric critical care patients: A systematic review of the literature and meta‐analysis. Paediatr. Anaesth., 2017, 27(3), 228-239. doi: 10.1111/pan.13056 PMID: 28109052
  114. Ye, J.; Myung, K.; Packiasabapathy, S.; Yu, J.S.; Jacobson, J.E.; Whittaker, S.C.; Castelluccio, P.; Drayton Jackson, M.; Sadhasivam, S. Methadone-based multimodal analgesia provides the best-in-class acute surgical pain control and functional outcomes with lower opioid use following major posterior fusion surgery in adolescents with idiopathic scoliosis. Pediatr. Qual. Saf., 2020, 5(4), e336. doi: 10.1097/pq9.0000000000000336 PMID: 32766507
  115. Boisvert-Plante, V.; Poulin-Harnois, C.; Ingelmo, P.; Einhorn, L.M. What we know and what we don’t know about the perioperative use of methadone in children and adolescents. Paediatr. Anaesth., 2022. PMID: 36281540
  116. Friedrichsdorf, S.J.; Kang, T.I. The management of pain in children with life-limiting illnesses. Pediatr. Clin. North Am., 2007, 54(5), 645-672. x. doi: 10.1016/j.pcl.2007.07.007 PMID: 17933616
  117. Anghelescu, D.L.; Faughnan, L.G.; Hankins, G.M.; Ward, D.A.; Oakes, L.L. Methadone use in children and young adults at a cancer center: A retrospective study. J. Opioid. Manag., 2011, 7(5), 353-361. doi: 10.5055/jom.2011.0076 PMID: 22165034
  118. Hall, E.A.; Sauer, H.E.; Habashy, C.; Anghelescu, D.L. Methadone for cancer pain in pediatric end-of-life care. Am. J. Hosp. Palliat. Care, 2021, 38(8), 914-919. doi: 10.1177/1049909120963641 PMID: 33000633
  119. Habashy, C.; Springer, E.; Hall, E.A.; Anghelescu, D.L. Methadone for pain management in children with cancer. Paediatr. Drugs, 2018, 20(5), 409-416. doi: 10.1007/s40272-018-0304-2 PMID: 30047027
  120. Vo, T.; Rice, A.S.C.; Dworkin, R.H. Non-steroidal anti-inflammatory drugs for neuropathic pain: How do we explain continued widespread use? Pain, 2009, 143(3), 169-171. doi: 10.1016/j.pain.2009.03.013 PMID: 19362418
  121. Moore, R.A.; Chi, C.C.; Wiffen, P.J.; Derry, S.; Rice, A.S. Oral nonsteroidal anti‐inflammatory drugs for neuropathic pain. Cochrane Database Syst. Rev., 2015, 2015(10), CD010902. doi: 10.1002/14651858.CD010902.pub2 PMID: 26436601
  122. Zamproni, L.N.; Ribeiro, R.T.; Cardeal, M. Treatment of recurrent painful ophthalmoplegic neuropathy: A case where pregabalin was successfully employed. Case Rep. Neurol. Med., 2019, 2019, 1-5. doi: 10.1155/2019/9185603 PMID: 30881712
  123. Myers, K.A.; Barmherzig, R.; Raj, N.R.; Berrahmoune, S.; Ingelmo, P.; Saint-Martin, C.; Khan, A.Q.; Kouri, M.; Morris, C.; Hershey, A.D.; Kacperski, J.; Kabbouche, M.A.; Mohamed, N.; Rao, R.R.; Lagman-Bartolome, A.M.; Gelfand, A.A.; Szperka, C.L.; Orr, S.L. The spectrum of indomethacin-responsive headaches in children and adolescents. Cephalalgia, 2022, 42(8), 793-797. doi: 10.1177/03331024221076483 PMID: 35302385
  124. Hall, E.A.; Sauer, H.E.; Davis, M.S.; Anghelescu, D.L. Lidocaine infusions for pain management in pediatrics. Paediatr. Drugs, 2021, 23(4), 349-359. doi: 10.1007/s40272-021-00454-2 PMID: 34036532
  125. Yang, X.; Wei, X.; Mu, Y.; Li, Q.; Liu, J. A review of the mechanism of the central analgesic effect of lidocaine. Medicine (Baltimore), 2020, 99(17), e19898. doi: 10.1097/MD.0000000000019898 PMID: 32332666
  126. Sugimoto, M.; Uchida, I.; Mashimo, T. Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-D-aspartate (NMDA) receptors. Br. J. Pharmacol., 2003, 138(5), 876-882. doi: 10.1038/sj.bjp.0705107 PMID: 12642389
  127. Araujo, M.C.; Sinnott, C.J.; Strichartz, G.R. Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: responses to early and late infusions. Pain, 2003, 103(1), 21-29. doi: 10.1016/S0304-3959(02)00350-0 PMID: 12749955
  128. Masic, D.; Liang, E.; Long, C.; Sterk, E.J.; Barbas, B.; Rech, M.A. Intravenous lidocaine for acute pain: A systematic review. Pharmacotherapy, 2018, 38(12), 1250-1259. doi: 10.1002/phar.2189 PMID: 30303542
  129. Zhu, B.; Zhou, X.; Zhou, Q.; Wang, H.; Wang, S.; Luo, K. Intra-venous lidocaine to relieve neuropathic pain: A systematic review and meta-analysis. Front. Neurol., 2019, 10, 954. doi: 10.3389/fneur.2019.00954 PMID: 31620064
  130. Kim, Y.C.; Castañeda, A.M.; Lee, C.; Jin, H.S.; Park, K.S.; Moon, J.Y. Efficacy and safety of lidocaine infusion treatment for neuropathic pain. Reg. Anesth. Pain Med., 2018, 43(4), 415-424. doi: 10.1097/AAP.0000000000000741 PMID: 29381569
  131. van den Heuvel, S.A.S.; van der Wal, S.E.I.; Smedes, L.A.; Radema, S.A.; van Alfen, N.; Vissers, K.C.P.; Steegers, M.A.H. Intravenous lidocaine: Old-school drug, new purpose-reduction of intractable pain in patients with chemotherapy induced peripheral neuropathy. Pain Res. Manag., 2017, 2017, 8053474. PMID: 28458593
  132. Hutson, P.; Backonja, M.; Knurr, H. Intravenous lidocaine for neuropathic pain: A retrospective analysis of tolerability and efficacy. Pain Med., 2015, 16(3), 531-536. doi: 10.1111/pme.12642 PMID: 25530475
  133. Tremont-Lukats, I.W.; Hutson, P.R.; Backonja, M.M. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain. Clin. J. Pain, 2006, 22(3), 266-271. doi: 10.1097/01.ajp.0000169673.57062.40 PMID: 16514327
  134. Mooney, J.J.; Pagel, P.S.; Kundu, A. Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: A preliminary report. Pain Med., 2014, 15(5), 820-825. doi: 10.1111/pme.12333 PMID: 24423053
  135. Puri, L.; Morgan, K.J.; Anghelescu, D.L. Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell disease. Curr. Opin. Support. Palliat. Care, 2019, 13(4), 402-407. doi: 10.1097/SPC.0000000000000437 PMID: 31157658
  136. Massey, G.V.; Pedigo, S.; Dunn, N.L.; Grossman, N.J.; Russell, E.C. Continuous lidocaine infusion for the relief of refractory malignant pain in a terminally ill pediatric cancer patient. J. Pediatr. Hematol. Oncol., 2002, 24(7), 566-568. doi: 10.1097/00043426-200210000-00015 PMID: 12368697
  137. Gibbons, K.; DeMonbrun, A.; Beckman, E.J.; Keefer, P.; Wagner, D.; Stewart, M.; Saul, D.A.; Hakel, S.; Liu, M.; Niedner, M. Continuous lidocaine infusions to manage opioid-refractory pain in a series of cancer patients in a pediatric hospital. Pediatr. Blood Cancer, 2016, 63(7), 1168-1174. doi: 10.1002/pbc.25870 PMID: 26784686
  138. Featherly, J.; Baxter Wojnowicz, S.; Steidl, K.; Burgess, J. Lidocaine for dinutuximab‐associated pain? A multicenter retrospective observational cohort study. Pediatr. Blood Cancer, 2022, 69(9), e29653. doi: 10.1002/pbc.29653 PMID: 35441791
  139. Voltarelli, J.C.; Ahmed, H.; Paton, E.J.A.; Stracieri, A.B.P.L.; Holman, P.; Bashey, A.; Coutinho, M.; Simoes, B.P.; Ball, E.D.; Carrier, E. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion. Bone Marrow Transplant., 2001, 28(1), 97-99. doi: 10.1038/sj.bmt.1703080 PMID: 11498752
  140. Wallace, M.S.; Lee, J.; Sorkin, L.; Dunn, J.S.; Yaksh, T.; Yu, A. Intravenous lidocaine. Anesth. Analg., 1997, 85(4), 794-796. doi: 10.1213/00000539-199710000-00014 PMID: 9322457
  141. Kajiume, T.; Sera, Y.; Nakanuno, R.; Ogura, T.; Karakawa, S.; Kobayakawa, M.; Taguchi, S.; Oshita, K.; Kawaguchi, H.; Sato, T.; Kobayashi, M. Continuous intravenous infusion of ketamine and lidocaine as adjuvant analgesics in a 5-year-old patient with neuropathic cancer pain. J. Palliat. Med., 2012, 15(6), 719-722. doi: 10.1089/jpm.2011.0097 PMID: 22401313
  142. Finholt, D.A.; Stirt, J.A.; DiFazio, C.A.; Moscicki, J.C. Lidocaine pharmacokinetics in children during general anesthesia. Anesth. Analg., 1986, 65(3), 279-282. doi: 10.1213/00000539-198603000-00010 PMID: 3954094
  143. Wallace, M.S.; Dyck, B.J.; Rossi, S.S.; Yaksh, T.L. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain, 1996, 66(1), 69-77. doi: 10.1016/0304-3959(96)02980-6 PMID: 8857633
  144. Baron, R.; Allegri, M.; Correa-Illanes, G.; Hans, G.; Serpell, M.; Mick, G.; Mayoral, V. The 5% lidocaine-medicated plaster: Its inclusion in international treatment guidelines for treating localized neuropathic pain, and clinical evidence supporting its use. Pain Ther., 2016, 5(2), 149-169. doi: 10.1007/s40122-016-0060-3 PMID: 27822619
  145. Amato, F.; Duse, G.; Consoletti, L.; Lo Presti, C.; Firetto, V.; Ciliberto, G.; Parigi, L.A.; Palmieri, V.; Mazza, M. Efficacy and safety of 5% lidocaine-medicated plasters in localized pain with neuropathic and/or inflammatory characteristics: an observational, real-world study. Eur. Rev. Med. Pharmacol. Sci., 2017, 21(18), 4228-4235. PMID: 29028074
  146. Palladini, M.; Boesl, I.; Koenig, S.; Buchheister, B.; Attal, N. Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: Efficacy and safety results of a randomized, placebo-controlled trial. Curr. Med. Res. Opin., 2019, 35(5), 757-766. doi: 10.1080/03007995.2019.1565709 PMID: 30614286
  147. Rousseau, V.; Morelle, M.; Arriuberge, C.; Darnis, S.; Chabaud, S.; Launay, V.; Thouvenin, S.; Roumenoff-Turcant, F.; Metzger, S.; Tourniaire, B.; Marec-Berard, P. Efficacy and tolerance of lidocaine 5% patches in neuropathic pain and pain related to vaso-occlusive sickle cell crises in children: A prospective multicenter clinical study. Pain Pract., 2018, 18(6), 788-797. doi: 10.1111/papr.12674 PMID: 29266772
  148. Nayak, S.; Cunliffe, M. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: Report of five cases. Paediatr. Anaesth., 2008, 18(6), 554-558. doi: 10.1111/j.1460-9592.2008.02491.x PMID: 18363625
  149. Rasolofo, J.; Poncelet, M.; Rousseau, V.; Marec-Berard, P. Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease. Arch. Pediatr., 2013, 20(7), 762-767. doi: 10.1016/j.arcped.2013.04.013 PMID: 23731603
  150. Goddard, J.M.; Reaney, R.L. Lidocaine 5%-medicated plaster (Versatis) for localised neuropathic pain: results of a multicentre evaluation of use in children and adolescents. Br. J. Pain, 2018, 12(3), 189-193. doi: 10.1177/2049463718756431 PMID: 30057764
  151. Hauer, J.; Houtrow, A.J.; Feudtner, C.; Klein, S.; Klick, J.; Linebarger, J.; Norwood, K.W., Jr; Adams, R.C.; Brei, T.J.; Davidson, L.F.; Davis, B.E.; Friedman, S.L.; Hyman, S.L.; Kuo, D.Z.; Noritz, G.H.; Yin, L.; Murphy, N.A. Pain assessment and treatment in children with significant impairment of the central nervous system. Pediatrics, 2017, 139(6), e20171002. doi: 10.1542/peds.2017-1002 PMID: 28562301
  152. Burns, J.; Jackson, K.; Sheehy, K.A.; Finkel, J.C.; Quezado, Z.M. The use of dexmedetomidine in pediatric palliative care: A preliminary study. J. Palliat. Med., 2017, 20(7), 779-783. doi: 10.1089/jpm.2016.0419 PMID: 28186850
  153. Ammerman, S.; Ryan, S.; Adelman, W.P.; Levy, S.; Ammerman, S.D.; Gonzalez, P.K.; Ryan, S.A.; Siqueira, L.M.; Smith, V.C.; Braverman, P.K.; Adelman, W.P.; Alderman, E.M.; Breuner, C.C.; Levine, D.A.; Marcell, A.V.; O’Brien, R.F. The impact of marijuana policies on youth: Clinical, research, and legal update. Pediatrics, 2015, 135(3), e769-e785. doi: 10.1542/peds.2014-4147 PMID: 25624383
  154. Taylor, M.; Jakacki, R.; May, C.; Howrie, D.; Maurer, S. Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics. Am. J. Hosp. Palliat. Care, 2015, 32(8), 841-848. doi: 10.1177/1049909114543640 PMID: 25028743
  155. Benini, F.; Congedi, S.; Giacomelli, L.; Papa, S.; Shah, A.; Milani, G. Refractory symptoms in paediatric palliative care: Can ketamine help? Drugs Context, 2021, 10, 1-9. doi: 10.7573/dic.2021-2-5 PMID: 34104198
  156. Sheehy, K.A.; Muller, E.A.; Lippold, C.; Nouraie, M.; Finkel, J.C.; Quezado, Z.M.N. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: A longitudinal study. BMC Pediatr., 2015, 15(1), 198. doi: 10.1186/s12887-015-0515-4 PMID: 26620833
  157. Derry, S.; Rice, A.S.; Cole, P.; Tan, T.; Moore, R.A. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst. Rev., 2017, 1(1), CD007393. PMID: 28085183
  158. Glaros, A.K.; Callaghan, M.U.; Smith, W.R.; Zaidi, A.U. Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease. eJHaem, 2022, 3(3), 653-659. doi: 10.1002/jha2.528 PMID: 36051054
  159. Cavalli, E.; Mammana, S.; Nicoletti, F.; Bramanti, P.; Mazzon, E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int. J. Immunopathol. Pharmacol., 2019, 33. doi: 10.1177/2058738419838383 PMID: 30900486
  160. Afshari, K.; Dehdashtian, A.; Haddadi, N.S.; Haj-Mirzaian, A.; Iranmehr, A.; Ebrahimi, M.A.; Tavangar, S.M.; Faghir-Ghanesefat, H.; Mohammadi, F.; Rahimi, N.; Javidan, A.N.; Dehpour, A.R. Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: Introduction of an alternative therapy. Spinal Cord, 2018, 56(11), 1032-1041. doi: 10.1038/s41393-018-0168-x PMID: 29959433
  161. Vieira, G.; Cavalli, J.; Gonçalves, E.C.D.; Gonçalves, T.R.; Laurindo, L.R.; Cola, M.; Dutra, R.C. Effects of simvastatin beyond dyslipidemia: Exploring its antinociceptive action in an animal model of complex regional pain syndrome-type I. Front. Pharmacol., 2017, 8, 584. doi: 10.3389/fphar.2017.00584 PMID: 28928655
  162. Kandhare, A.D.; Mukherjee, A.A.; Bodhankar, S.L. Neuroprotective effect of Azadirachta indica standardized extract in partial sciatic nerve injury in rats: Evidence from anti-inflammatory, antioxidant and anti-apoptotic studies. EXCLI J., 2017, 16, 546-565. PMID: 28694757
  163. Xia, Z-Y.; Xie, H-T.; Pan, X.; Zhao, B.; Liu, Z.G. Puerarin ameliorates allodynia and hyperalgesia in rats with peripheral nerve injury. Neural Regen. Res., 2018, 13(7), 1263-1268. doi: 10.4103/1673-5374.235074 PMID: 30028336
  164. Forte, G.; Giuffrida, V.; Scuderi, A.; Pazzaglia, M. Future treatment of neuropathic pain in spinal cord injury: The challenges of nanomedicine, supplements or opportunities? Biomedicines, 2022, 10(6), 1373. doi: 10.3390/biomedicines10061373 PMID: 35740395

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers